BICO Group AB engages in the provision of technologies, products, and services to create, understand, and master biology. The company is headquartered in Goeteborg, Vastra Gotalands and currently employs 695 full-time employees. The company went IPO on 2016-11-03. The firm focuses on the application areas of bioprinting, multiomics, cell line development, and diagnostics. The firm develops and markets technologies that enable researchers in the life sciences to culture cells in 3D, perform high-throughput drug screening and print human tissues and organs for the medical, pharmaceutical, and cosmetic industries. The Company’s operations divided in two segments: The Industrial Solutions segment that offers products within precision dispensing and biosensor technology for industrial customers, which make a high-capacity contribution to customers production; and The Laboratory Solutions segment that offers 3Dprinters, single- cell and liquid- dispensing instruments as well as services and consumables related to these products.
Follow-Up Questions
BCCOY 주식의 가격 성능은 어떻습니까?
BCCOY의 현재 가격은 $0.586이며, 전 거래일에 decreased 0% 하였습니다.
BICO Group AB의 주요 사업 주제나 업종은 무엇입니까?
BICO Group AB은 Life Sciences Tools & Services 업종에 속하며, 해당 부문은 Health Care입니다
BICO Group AB의 시가총액은 얼마입니까?
BICO Group AB의 현재 시가총액은 $40.4M입니다
BICO Group AB는 매수, 매도, 아니면 보유해야 하나요?
월스트리트 분석가들에 따르면, 7명의 분석가가 BICO Group AB에 대한 분석 평가를 실시했으며, 이는 2명의 강력한 매수, 6명의 매수, 1명의 보유, 0명의 매도, 그리고 2명의 강력한 매도를 포함합니다